The Noninvasive Urinary Polyomavirus Haufen Test Predicts BK Virus Nephropathy in Children after Hematopoietic Cell Transplantation: A Pilot Study

Transplantation

Volumn 100, Issue 10, 2016, Pages e81-e87

  Laskin, Benjamin L ^a   Singh, Harsharan K ^b   Beier, Ulf H ^a   Moatz, Taylor ^a   Furth, Susan L ^a   Bunin, Nancy ^a   Witte, David ^c   Goebel, Jens ^c   Davies, Stella M ^c   Dandoy, Christopher ^c   Jodele, Sonata ^c   Nickeleit, Volker ^b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIDOFOVIR; CIPROFLOXACIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; LEFLUNOMIDE;

ADOLESCENT; ARTICLE; AUTOPSY; BK VIRUS INFECTION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; DIALYSIS; DISEASE SEVERITY; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMORRHAGIC CYSTITIS; HIGH RISK PATIENT; HISTOPATHOLOGY; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY INFECTION; MALE; NON INVASIVE MEASUREMENT; NONHUMAN; PILOT STUDY; POLYOMAVIRUS HAUFEN TEST; POSTOPERATIVE PERIOD; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; URINALYSIS; VIREMIA; ADULT; ADVERSE EFFECTS; BK VIRUS; CASE CONTROL STUDY; ISOLATION AND PURIFICATION; KIDNEY DISEASES; POLYOMAVIRUS INFECTIONS; TUMOR VIRUS INFECTIONS; VIRUS SHEDDING;

ADOLESCENT; ADULT; BK VIRUS; CASE-CONTROL STUDIES; CHILD; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KIDNEY DISEASES; MALE; PILOT PROJECTS; POLYOMAVIRUS INFECTIONS; TUMOR VIRUS INFECTIONS; VIRUS SHEDDING;

EID: 84958781133     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000001085     Document Type: Article

References (29)

1. Hingorani S. Chronic kidney disease in long-term survivors of hematopoietic cell transplantation: epidemiology, pathogenesis, and treatment. J Am Soc Nephrol. 2006;17:1995-2005.
2. Nieder ML, McDonald GB, Kida A, et al. National cancer institute-national heart, lung and blood institute/pediatric blood andmarrowtransplant consortium first international consensus conference on late effects after pediatric hematopoietic cell transplantation: long-term organ damage and dysfunction. Biol Blood Marrow Transplant. 2011;17:1573-1584.
3. Nickeleit V,Mengel M, Colvin RB. Renal Transplant Pathology. In: Jennette JC, Olson JL, Silva FG, et al. editors. Heptinstall's Pathology of the Kidney. 7th edition. Philadelphia, PA: Wolters Kluwer; 2015:1321-1459.
4. Dropulic LK, Jones RJ. Polyomavirus BK infection in blood and marrow transplant recipients. Bone Marrow Transplant. 2008;41:11-18.
5. Erard V, Kim HW, Corey L, et al. BK DNA viral load in plasma: evidence for an association with hemorrhagic cystitis in allogeneic hematopoietic cell transplant recipients. Blood. 2005;106:1130-1132.
6. Lekakis LJ, Macrinici V, Baraboutis IG, et al. BK virus nephropathy after allogeneic stem cell transplantation: a case report and literature review. Am J Hematol. 2009;84:243-246.
7. Verghese PS, Finn LS, Englund JA, et al. BK nephropathy in pediatric hematopoietic stem cell transplant recipients. Pediatr Transplant. 2009;13: 913-918.
8. Sanchez-Pinto LN, Laskin BL, Jodele S, et al. BK virus nephropathy in a pediatric autologous stem-cell transplant recipient. Pediatr Blood Cancer. 2011;56:495-497.
9. Ramos E, Drachenberg CB, Wali R, et al. The decade of polyomavirus BK-associated nephropathy: state of affairs. Transplantation. 2009;87: 621-630.
10. Nickeleit V, Singh HK. Polyomaviruses and disease: is there more to know than viremia and viruria? Curr Opin Organ Transplant. 2015;20:348-358.
11. Nickeleit V, Mihatsch MJ. Polyomavirus nephropathy in native kidneys and renal allografts: an update on an escalating threat. Transpl Int. 2006;19: 960-973.
12. Changsirikulchai S,Myerson D, Guthrie KA, et al. Renal thromboticmicroangiopathy after hematopoietic cell transplant: role of GVHD in pathogenesis. Clin J Am Soc Nephrol. 2009;4:345-353.
13. Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant. 2009;9(Suppl 3):S1-S155.
14. Hirsch HH, Randhawa P; AST Infectious DiseasesCommunity of Practice. BK polyomavirus in solid organ transplantation. AmJ Transplant. 2013;13 (Suppl 4):179-188.
15. Hirsch HH, BrennanDC, Drachenberg CB, et al. Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation. 2005;79:1277-1286.
16. Hirsch HH, Knowles W, Dickenmann M, et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl JMed. 2002;347:488-496.
17. Laskin BL, Denburg M, Furth S, et al. BK viremia precedes hemorrhagic cystitis in children undergoing allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2013;19:1175-1182.
18. Singh HK, Andreoni KA, Madden V, et al. Presence of urinary Haufen accurately predicts polyomavirus nephropathy. J AmSoc Nephrol. 2009;20: 416-427.
19. Singh HK, Donna Thompson B, Nickeleit V. Viral Haufen are urinary biomarkers of polyomavirus nephropathy: new diagnostic strategies utilizing negative staining electron microscopy. Ultrastruct Pathol. 2009;33: 222-235.
20. Singh HK, Reisner H, Derebail VK, et al. Polyomavirus nephropathy: quantitative urinary polyomavirus-haufen testing accurately predicts the degree of intrarenal viral disease. Transplantation. 2015;99:609-615.
21. Nickeleit V, BrylawskiB, Singh H, et al. Urinary polyomavirus-Haufen shedding in mouse and man: a proof-of-concept study for a non-invasive urine biomarker for polyomavirus nephropathy. Mod Path. 2013;26:390A.
22. Schwartz GJ, Muñoz A, Schneider MF, et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol. 2009;20:629.
23. Haines HL, Laskin BL, Goebel J, et al. Blood, and not urine BK viral load predicts renal outcome in children with hemorrhagic cystitis following hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2011;17:1512-1519.
24. Elfadawy N, Flechner SM, Schold JD, et al. Transient versus persistent BK viremia and long-term outcomes after kidney and kidney-pancreas transplantation. Clin J Am Soc Nephrol. 2014;9:553-561.
25. Nickeleit V, Hirsch HH, Zeiler M, et al. BK-virus nephropathy in renal transplants-tubular necrosis MHC-class II expression and rejection in a puzzling game . Nephrol Dial Transplant. 2000;15:324-332.
26. Burger-Calderon R, Madden V, Hallett RA, et al. Replication of oral BK virus in human salivary gland cells. J Virol. 2014;88:559-573.
27. Dropulic LK, Cohen JI. Update on new antivirals under development for the treatment of double-stranded DNA virus infections. Clin Pharmacol Ther. 2010;88:610-619.
28. Knoll GA, Humar A, Fergusson D, et al. Levofloxacin for BK virus prophylaxis following kidney transplantation: a randomized clinical trial. JAMA. 2014;312:2106-2114.
29. Krisl JC, Taber DJ, Pilch N, et al. Leflunomide efficacy and pharmacodynamics for the treatment of BK viral infection. Clin J Am Soc Nephrol. 2012;7:1003-1009.